549 related articles for article (PubMed ID: 32992592)
1. Host Immune Response Driving SARS-CoV-2 Evolution.
Wang R; Hozumi Y; Zheng YH; Yin C; Wei GW
Viruses; 2020 Sep; 12(10):. PubMed ID: 32992592
[TBL] [Abstract][Full Text] [Related]
2. Host immune response driving SARS-CoV-2 evolution.
Wang R; Hozumi Y; Zheng YH; Yin C; Wei GW
ArXiv; 2020 Aug; ():. PubMed ID: 32839723
[TBL] [Abstract][Full Text] [Related]
3. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL
Chitranshi N; Gupta VK; Rajput R; Godinez A; Pushpitha K; Shen T; Mirzaei M; You Y; Basavarajappa D; Gupta V; Graham SL
J Transl Med; 2020 Jul; 18(1):278. PubMed ID: 32646487
[TBL] [Abstract][Full Text] [Related]
4. Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19.
Xu W; Wang M; Yu D; Zhang X
Front Immunol; 2020; 11():565278. PubMed ID: 33013929
[TBL] [Abstract][Full Text] [Related]
5. Characterization of codon usage pattern in SARS-CoV-2.
Hou W
Virol J; 2020 Sep; 17(1):138. PubMed ID: 32928234
[TBL] [Abstract][Full Text] [Related]
6. Point mutation bias in SARS-CoV-2 variants results in increased ability to stimulate inflammatory responses.
Kosuge M; Furusawa-Nishii E; Ito K; Saito Y; Ogasawara K
Sci Rep; 2020 Oct; 10(1):17766. PubMed ID: 33082451
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
Elife; 2020 May; 9():. PubMed ID: 32452762
[TBL] [Abstract][Full Text] [Related]
8. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).
Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y
Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
Kim CH
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
[TBL] [Abstract][Full Text] [Related]
10. Making a case for using γδ T cells against SARS-CoV-2.
Yazdanifar M; Mashkour N; Bertaina A
Crit Rev Microbiol; 2020 Nov; 46(6):689-702. PubMed ID: 33023358
[TBL] [Abstract][Full Text] [Related]
11. Genotyping coronavirus SARS-CoV-2: methods and implications.
Yin C
Genomics; 2020 Sep; 112(5):3588-3596. PubMed ID: 32353474
[TBL] [Abstract][Full Text] [Related]
12. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
[TBL] [Abstract][Full Text] [Related]
13. Overwhelming mutations or SNPs of SARS-CoV-2: A point of caution.
Vankadari N
Gene; 2020 Aug; 752():144792. PubMed ID: 32445924
[TBL] [Abstract][Full Text] [Related]
14. Modeling infectious disease dynamics.
Cobey S
Science; 2020 May; 368(6492):713-714. PubMed ID: 32332062
[No Abstract] [Full Text] [Related]
15. Early Insights into Immune Responses during COVID-19.
St John AL; Rathore APS
J Immunol; 2020 Aug; 205(3):555-564. PubMed ID: 32513850
[TBL] [Abstract][Full Text] [Related]
16. Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.
Li X; Zai J; Zhao Q; Nie Q; Li Y; Foley BT; Chaillon A
J Med Virol; 2020 Jun; 92(6):602-611. PubMed ID: 32104911
[TBL] [Abstract][Full Text] [Related]
17. The explosion of new coronavirus tests that could help to end the pandemic.
Guglielmi G
Nature; 2020 Jul; 583(7817):506-509. PubMed ID: 32681157
[No Abstract] [Full Text] [Related]
18. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
[TBL] [Abstract][Full Text] [Related]
19. The genetic landscape of COVID-19: A South Asian perspective.
Thomas V; Audsley J; Kapoor N
J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S38-S43. PubMed ID: 32515376
[TBL] [Abstract][Full Text] [Related]
20. Surviving COVID-19: A disease tolerance perspective.
Ayres JS
Sci Adv; 2020 May; 6(18):eabc1518. PubMed ID: 32494691
[No Abstract] [Full Text] [Related]
[Next] [New Search]
